HKHans J⊘Rn Kolmos

Hans J⊘Rn Kolmos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hans J⊘Rn Kolmos has a total of 2 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 13 September 1999
      • Vol. 161  (37) , 5161-4

    [Infections and cardiovascular disease].

    by H J Kolmos, C N Gluud

    Epidemiological studies indicate that respiratory tract and dental infections increase the risk of atherosclerotic cardiovascular disease. Several microorganisms have been claimed as clinically important, especially Chlamydia pneumoniae (Cp) and cytomegalovirus (CMV), Cp is frequently isolated from atherosclerotic plaques, and treatment with macrolide antibiotics may have a beneficial effect on the course of ischaemic heart disease. CMV seems to play a role in the development of coronary stenosis following coronary bypass surgery and heart transplantation. Likewise, inflammatory markers are associated with atherosclerotic cardiovascular disease. The pathogenetic role of microorganisms may be ascribed to the inflammatory response, which is elicited during infection. There is an urgent need for more documentation of the role of microorganisms in cardiovascular disease, and of the possible clinical effect of antibiotic treatment.

  • Controversies in management: Should general practitioners perform diagnostic tests on patients before prescribing antibiotics? For Against

    by Hans J⊘Rn Kolmos, Paul Little

    # Should general practitioners perform diagnostic tests on patients before prescribing antibiotics? {#article-title-2} As most antibiotics are prescribed by general practitioners, control of antibiotic resistance depends greatly on rational prescribing behaviour by these doctors. Here a Danish microbiologist argues for near patient testing before prescribing antibiotics, while a British general practitioner contends that there are considerable problems associated with testing and that time is often the best treatment for acute, self limiting infections. # For {#article-title-3} As 80% of antibiotics are prescribed by general practitioners,1 control of antibiotic resistance depends greatly on rational prescribing behaviour in this group of doctors. Microbiological testing is an important tool in rational prescribing of antibiotics, not only in hospitals but also in general practice. However, the usefulness of laboratory based testing may be limited if it takes too long—particularly in patients who are considered to need immediate antibiotic treatment. These patients will therefore be treated empirically, and test results received afterwards from the laboratory may have little influence on the course of treatment. One way of overcoming these problems is to perform near patient microbiological testing. In Denmark, many general practitioners undertake selected microbiological tests using phase contrast microscopy and simple diagnostic kits. 2 3 Practice based microbiological testing has several advantages. Most importantly, the test result can be available immediately, and this helps to decide whether the patient should be prescribed antibiotics. General practitioners are often under pressure from patients who believe they need antibiotics.4 With a negative test result at hand it is much easier for the doctor to refuse to prescribe an unnecessary antibiotic. Furthermore, if the patient needs treatment immediately, the test result may help in choosing the most appropriate agent. Near patient testing also reduces bureaucracy. General practitioners do not have to spend time filling in the forms that have to accompany specimens sent to the laboratory, communication problems with the laboratory are …